Zhongnan Medical Journal Press

Home Results

A total of 29 result was found. Results that relate to Rapid health technology assessment

Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1156-1163.
10689 times 1976 times

HUANG Gerile LI Yujie ZHANG Wenjing GUO Hao

Efgartigimod alfa Myasthenia gravis Rapid health technology assessment Efficaey Safety Economy
Details
Tofacitinib for the treatment of ulcerative colitis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(12):1414-1424.
16672 times 1836 times

LI Huiling DUAN Yinyin LI Qianqian WU Xiaoli

Tofacitinib Ulcerative colitis Rapid health technology assessment
Details
Vonoprazan for ulcers associated with endoscopic submucosal dissection: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):306-313.
9689 times 1657 times

WANG Wei KE Yijun CHENG Chang FANG Chongwen PAN Lisheng JIN Yong ZHANG Yanping

Vonoprazan Endoscopic submucosal dissection Ulcer Rapid health technology assessment
Details
Venetoclax in the treatment of non-M3 acute myeloid leukemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):314-323.
10471 times 1575 times

ZHANG Yazhuo LI Huiling Duan Yinyin SHI Yuye

Venetoclax Non-M3 acute myeloid leukemia Rapid health technology assessment
Details
Dorzagliatin in the treatment of type 2 diabetes：a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):448-455.
15388 times 3067 times

LI Yujie ZHANG Wenjing YANG Hongxin GUO Hao

Dorzagliatin Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Economy
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
8739 times 1320 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1057-1065.
11790 times 1464 times

ZHANG Yunxuan ZHOU Haifeng GAO Ningzhou WU Jianbo QIAN Cheng ZHANG Min GUO Han SONG Zhongjuan LIU Xiaoyan

Tirzepatide Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Cost-effectiveness
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1198-1205.
5923 times 1088 times

CHEN Lingbin PAN Weiping CHEN Zhou XU Wentan

Inclisiran Dyslipidemia Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Rapid health technology assessment of linezolid for the treatment of complicated lower respiratory tract infections

Published on Frontiers in Pharmaceutical Sciences 2025,29(10):1731-1737.
4395 times 732 times

LANG Yan PAN Jiahui WANG Ling

Linezolid Lower respiratory tract infection Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
4023 times 746 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1311-1319.
4419 times 782 times

LI Zhou LING Ya ZHANG Jie ZHU Ling

Avatrombopag Primary immune thrombocytopenia Efficacy Safety Economy Rapid health technology assessment
Details
Rapid health technology assessment of crisaborole in the treatment of mild-to-moderate atopic dermatitis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1423-1433.
3829 times 630 times

ZHANG Jinfen TONG Ruofei YANG Lin SUN Yanyan

Crisaborole Atopic dermatitis Rapid health technology assessment Efficacy Safety Economy
Details
Oliceridine injection for postoperative analgesia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1434-1440.
3040 times 622 times

ZHOU Jing LUO Hao ZHENG Xiaoke CAI Jingyue XIE Caipeng TAN Qiuhua

Oliceridine Postoperative analgesia Efficacy Safety Economy Rapid health technology assessment
Details
Rapid health technology assessment of PARP inhibitors in the treatment of recurrent ovarian cancer

Published on Chinese Journal of Pharmacoepidemiology 2026,35(4):439-450.
1320 times 223 times

LI Anna LI Jianping CHEN Wenjun ZUO Jing HUANG Xiaolu MENG Jun

Poly ADP ribose polymerase inhibitors Recurrent ovarian cancer Rapid health technology assessment Efficacy Safety Economy
Details